JOURNAL HOME CME HOME THIS MONTH PAST ISSUES ETOC COLLECTIONS AUTHORS REVIEWERS EDITORIAL BOARD FEEDBACK RSS HELP
		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Woehlck, H. Articles by Kaslow, O. Search for Related Content PubMed PubMed Citation Articles by Woehlck, H. Articles by Kaslow, O. Related Collections Monitoring (Non-cardiac) Pharmacology

---

TECHNOLOGY, COMPUTING, AND SIMULATION

Safe Use of Pulse Oximetry During Verteporphin Therapy

Harvey Woehlck, MD^*, Dave Herrmann, PharmD, and Olga Kaslow, MD^*

Departments of Anesthesiology, *Medical College of Wisconsin; and Froedtert Memorial Lutheran Hospital, Milwaukee, Wisconsin

Address correspondence and reprint requests to Harvey Woehlck, MD, Department of Anesthesiology, Froedtert Memorial Lutheran Hospital West, 9200 W. Wisconsin Ave., Milwaukee, WI 53226. Address e-mail to hwoehlck{at}mcw.edu

IMPLICATIONS: Pulse oximetry may produce skin damage after the administration of photosensitizing chemotherapeutic drugs. Surgery must often be performed in near darkness during photodynamic therapy. Limiting the duration of pulse oximetry and rotating sites allowed successful use of pulse oximetry in a long anesthetic during which verteporphin was administered.

Anesthesia & Analgesia® is published for the International Anesthesia Research Society® by Lippincott Williams & Wilkins with the assistance of Stanford University Libraries' HighWire Press®. Copyright 2006 by the International Anesthesia Research Society. Online ISSN: 1526-7598   Print ISSN: 0003-2999